Application of Carbon Quantum Dots as Biocompatible Luminous Materials in Regenerative Medicine
YANG Lei1, YANG Zhi2, LIAN Feng1
1 Department of Cardiovascular Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127; 2 Ministry of Education Key Laboratory of Thin Film and Microfabrication Technology, School of Electronic Information and Electrical Engineering, Shanghai Jiao Tong University, Shanghai 200240
Abstract: Carbon nanomaterials (CNMs) have attracted the attention of the scientific community because of their role in electronic, optical, thermal and mechanical properties and multi-purpose functional chemistry. Because of their inherent hydrophobicity, carbon nanomaterials have more biocompatibility and safety than metal-based nanomaterials. Carbon nanomaterials (CNMs) can be used as an efficient drug delivery platform by hydrophobic interaction or π-π stacking. In recent years, graphene, fullerene, carbon nanotubes and carbon quantum dots have become the most widely used carbon nanomaterials for the treatment of cancer and intracellular labeling. These carbon nanomaterials can be biocompatible by covalent or non-covalent modification. Covalent modification is the introduction of hydroxyl, carboxy or amino groups on its surface. These free radicals further bind to the protective biopolymer polyethylene glycol (PEG), while the non-covalent modification is supported on CNMs. These carbon-based nanomaterials have been proved to be not only good loading carriers for various biological macromolecules, but also good photosensitizers. In addition, many ideal functionalization can be integrated into CNMs for active targeting and homing of tumors. Because of the inhe-rent optical properties of CNMs, many researchers have also studied its application in tumor cell and stem cell imaging, and proved that they are reliable materials in future biological imaging. Among many carbon-based nanomaterials, carbon quantum dots (CQDs) have not only attracted people’s attention in the field of materials but also attracted great interest in biological applications because of their special zero-dimensional structure and excellent properties. In the past decade, the development of biological macromolecules such as genes, growth factors and other biological macromolecules to stem cells has led to the exploration of the possibility of improving the treatment of human diseases through nano-drug therapy. However, although great progress has been made, many key technical problems need to be solved before this nanodrug therapy can be used safely and effectively in the clinical environment. For example, after transplantation of stem cells to ischemic area, due to the change of microenvironment, the survival and migration of stem cells are monitored. In this paper, the progress of these nanodrug therapy is reviewed, with emphasis on the advanced carbon quantum dot nanoparticles technology to monitor the position of stem cells in vivo and in vitro after therapeutic transplantation, as well as the tracer and manipulation of macromolecules in living cells.
作者简介: 杨磊,上海交通大学医学院附属仁济医院心血管外科硕士研究生,现攻读硕士二年级,主要研究方向为纳米材料调控干细胞,及其介导的心肌再生,缺血再灌注后的心肌修复。 连锋博士,主任医师,心血管外科行政副主任,上海交通大学硕士研究生导师,中华医学会心胸血管外科分会会员,中国医师协会会员,仁济医院青联委员。1994年获得医学学士学位,开始心胸外科工作。师从我国著名心脏外科专家朱洪生教授,2000年获得上海交通大学医学院硕士学位,2003年获得上海交通大学医学院博士学位。同年荣获上海市“宝钢教育奖”,赴中国香港大学玛丽医院学习。2006年入选上海交通大学医学院“百人计划”,赴美国排名第一的心脏中心——克利夫兰医学中心(CLEVELAND CLINIC)访问学者学习。2007年3月至2008年3月在意大利国立帕维亚大学(Università degli Studi di PAVIA)附属圣马窦医院(IRCCS POLICLINICO SAN MATTEO)心脏外科临床访问学者从事临床工作,主修冠脉搭桥,瓣膜外科,先天性心脏病和微创心脏外科,在意大利期间参加各种心脏手术(包括各种微创微创心脏手术,da Vinci机器人手术,心脏移植,肺移植等)近500台,主刀冠脉搭桥等各种心脏手术近100台,回国获得中国教育部颁发的归国人员留学证书。
引用本文:
杨磊, 杨志, 连锋. 碳量子点作为生物相容性发光材料在再生医学方面的应用[J]. 材料导报, 2019, 33(Z2): 1-9.
YANG Lei, YANG Zhi, LIAN Feng. Application of Carbon Quantum Dots as Biocompatible Luminous Materials in Regenerative Medicine. Materials Reports, 2019, 33(Z2): 1-9.
1 Bongso A, Lee E H. In: Stem Cell, World Scientific Publishing Co: Singapore,2005. 2 Biffi A, De Palma M, Quattrini A, et al. Journal of Clinical Investigation,2004,113,1118. 3 Biffi A, Capotondo A, Fasano S, et al. Journal of Clinical Investigation,2006,116,3070. 4 Ryan J M, Barry F P, Murphy J M, et al. Journal of Inflammation-Mation,2005,2,1. 5 Ryan J M, Barry F, Murphy J M. Clinical and Experimental Immunology,2007,149,353. 6 Fischer U M, Harting M T, Jimenez F, et al. Stem Cells and Development,2009,18,683. 7 Roobrouk V D, Ulloa-Montoya F, Verfaillie C M, et al. Experimental Cell Research,2008,314,1937. 8 Jing X, Yang L, Duan X, et al. Joint Bone Spine,2008,75,432 9 Lee N, Choi S H, Hyeon T, et al. Advanced Materials,2013,25,2641 10 Subramani K, Hosseinkhani H, Khraisat A, et al. Current Nanoscience,2009,5,135. 11 Aoyama T, Hosseinkhani H, Yamamoto S, et al. Journal of Controlled Release, 2002, 80, 345. 12 Hosseinkhani H, Hosseinkhani M. Current Drug Safety,2009,4,79. 13 Meng H, Xing G, Sun B, et al. ACS Nano,2010,4,2773. 14 Jiao F, Liu Y, Qu Y, et al. Carbon,2010,48,2231. 15 Sun C, Wang L, Gao D, et al. Nanoscale, 2016,8,16332. 16 Pan Y, Wang L, Kang S G, et al. ACS Nano,2015,9,6826. 17 Zhou Y, Deng R, Zhen M, et al. Biomaterials,2017,133,107. 18 Vollath D D, Szabo V, Haubelt, et al. Journal of the European Ceramic Society,1997,17,1317. 19 Jones M C, Leroux J C, European Journal of Pharmaceutics And Biopharmaceutics,1999,48,101. 20 Granot D, Nkansah M K, Bennewitz M F, et al. Magnetic Resonance in Medicine,2014,71,1238. 21 Imrie C T, Henderson P A. Chemical Society Reviews,2007,36,2096. 22 Shao D, Lu M, Xu D, Zheng X, et al. Biomaterials Science,2017,22(5),1820. 23 Chen D, Li Q, Meng Z, et al. Theranostics,2017,7(7),1820. 24 Meng Z, Guo L, Li Q.Chemistry,2017,23(28),6836. 25 Kim T, Lee N, Arifin D R, et al. Advanced Functional Materials,2017,27(3),19. 26 Zheng X T, Than A, Ananthanaraya A, et al. ACS Nano,2013,7(7),6278. 27 Han Q, Dong W, Wang H, et al. Chemosphere,2019,27,235. 28 Wang Z, Xia J, Zhou C, et al. Colloids and Surfaces B-Biointerfaces,2013,112,192. 29 Liu W, Howarth M, Greytak A B, et al. Journal of the American Chemical Society,2008,130(4),1274. 30 Zhang M, Bai L, Shang W, et al. Materials Today Chemistry,2012,22,7461. 31 Shang W, Zhang X, Zhang M, et al. Nanoscale,2014,6,5799. 32 Markovic Z M, Ristic B Z, Arsikin K M, et al. Biomaterials,2012,33,7084. 33 Hild W A, Breunig M ,Goepferich A, et al. European Journal of Pharmaceutics and Biopharmaceutics,2008,68,153. 34 Zhang X, Hu W, Li J, et al. Toxicology Research,2012,1,62. 35 Wang K, Ruan J, Song H, et al. Nanoscale Research Letters,2011,6(1),8. 36 Popovtzer R, Agrawal A, Kotov N A, et al. Nano Letters,2008,8,4593. 37 Xu C J, Tung G A, Sun S H, et al. Chemistry of Materials,2008,20,4167. 38 Connor E E, Mwamuka J, Gole A, et al. Small,2005,1,325. 39 Luo P G, Sahu S, Yang S T. et al. Journal of Materials Chemistry,2013,1,2116. 40 Luo P G, Sonkar S K, Yang S T. et al. RSC Advances,2014,4,10791. 41 Wang Y, Hu, A. Journal of Materials Chemistry,2014,2,6921. 42 Lim S Y, Shen W, Gao Z. Chemical Society Reviews,2015,44,362. 43 Miao P, Han K, Tang Y, et al. Nanoscale,2015,7,1586. 44 Zhao A, Chen Z, Zhao C. et al. Carbon,2015,85,309. 45 Cao L, Wang X, Meziani M. et al. Journal of the American Chemical So-ciety,2007,129(37),11318. 46 Zhang X, Wang S, Xu L. et al. Nanoscale,2012,4,5581. 47 Chen B, Li F, Li S. et al. Nanoscale,2013,5,1967. 48 Yang L, Jiang W, Qiu L. et al. Nanoscale,2015,7,6104. 49 Liu J H, Cao L, LeCroy G E, et al. ACS Applied Materials & Interfaces.2015,7(34),310. 50 Hu S, Zhou Y, Zhao Y, et al . Tissue Engineering and Regenerative Me-dicine,2018,12(4),2085. 51 Yang Y, Zhang J, Qian Y, et al. Ann Biomed Engannals of Biomedical Engineering,2013,41(10),2109. 52 Huang Z, Li C, Yang S, Xu J, et al. International Journal of Nanomedicine,2015,2(10),1679. 53 Furman-Haran E, Margalit R, Grobgeld D, et al.Magn Reson Med,1998,8(3),634. 54 Donnelly E M, Kubelick K P, Dumani D S, et al. Nano Letters,2018,18(10),6625. 55 Betzer O, Shwartz A, Motiei M, et al. ACS Nano,2014,8(9),9274. 56 Zhang Y S, Wang Y, Wang L, et al. Theranostics,2013,3(8),532. 57 Drey F, Choi Y H, Neef K, et al. Cell Transplantation,2013,22(11),1971. 58 Zheng X T, Than A, Ananthanaraya A, et al. ACS Nano.2013,7(7),6278. 59 Wang X, Sun X, Lao J, et al. Colloids and Surfaces B-Biointerfaces,2014,122,638. 60 Kim J, Song S H, Jin Y, et al. Nanoscale.2016,8(16),8512. 61 Liu J H, Cao L, LeCroy G E, et al. ACS Applied Materials & Interfaces,2015,7(34),310. 62 Han G, Zhao J, Zhang R, et al. Angewandte Chemie-International Edition,2019,58(21),20. 63 Dong H, Dai W, Ju H, et al. ACS Applied Materials & Interfaces,2015,7(1),20. 64 Chen S, Weitemier A Z, Zeng X, et al. Science,2018,359(6376),679. 65 Junyan Y, Shulan H, Yanzhen Y, et al. Colloids and Surfaces B-Biointerfaces,2018,171,241. 66 Yang S T, Wang X, Wang H, et al. Biophysical Chemistry,2009,18,110.